KRISTINA SNYDER: Open Payments
NPI 1790259406 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,055 in 145 payments from 16 companies in 2025. Trend: 2023 $2,946 · 2024 $2,713 · 2025 $3,055
Food & beverage: $3,055
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,011 |
| Madrigal Pharmaceuticals | 12 | $490 |
| Phathom Pharmaceuticals, Inc. | 23 | $321 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $217 |
| Novo Nordisk Inc | 4 | $174 |
| Janssen Biotech, Inc. | 8 | $163 |
| Gilead Sciences, Inc. | 10 | $160 |
| Ipsen Biopharmaceuticals, Inc | 4 | $157 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| QOL Medical, LLC | 3 | $67 |
Products named: REZDIFFRA, RINVOQ, VOQUEZNA, CREON, LINZESS, XIFAXAN, Wegovy, TREMFYA.
Industry payments across OK — which companies pay providers there.
